Skip to main content
. 2022 Aug 28;11(17):2674. doi: 10.3390/cells11172674

Figure 4.

Figure 4

rTcpC inhibits M1 markers CD80 and CD86 but promotes the expression of M2 markers CD163 and CD206 in macrophages. (AD) The effects of rTcpC on M1 surface markers CD80 and CD86 detected by flow cytometry and FI were analyzed by FlowJo v10.0.7 software. (EH) The surface markers CD163 and CD206 of M2 polarized macrophages were detected by flow cytometry. Mean ± SD of three independent experiments are shown. **: p < 0.01.